Legis Daily

Medicare Buy-In and Health Care Stabilization Act of 2019

USA116th CongressHR-1346| House 
| Updated: 12/10/2019
Brian Higgins

Brian Higgins

Democratic Representative

New York

Cosponsors (51)
Tim Ryan (Democratic)Jared F. Golden (Democratic)Gilbert Ray Cisneros (Democratic)Adam B. Schiff (Democratic)James R. Langevin (Democratic)Ed Case (Democratic)Kathleen M. Rice (Democratic)Darren Soto (Democratic)John A. Yarmuth (Democratic)Max Rose (Democratic)Joe Courtney (Democratic)Pete Aguilar (Democratic)Dina Titus (Democratic)Michael F. Doyle (Democratic)Suzan K. DelBene (Democratic)Paul Tonko (Democratic)Wm. Lacy Clay (Democratic)Collin C. Peterson (Democratic)Anthony G. Brown (Democratic)Ann Kirkpatrick (Democratic)Daniel T. Kildee (Democratic)Ro Khanna (Democratic)Alan S. Lowenthal (Democratic)Ann M. Kuster (Democratic)Sean Patrick Maloney (Democratic)Brendan F. Boyle (Democratic)Matt Cartwright (Democratic)John B. Larson (Democratic)Gregory W. Meeks (Democratic)David E. Price (Democratic)Hakeem S. Jeffries (Democratic)Raja Krishnamoorthi (Democratic)Theodore E. Deutch (Democratic)Eleanor Holmes Norton (Democratic)Mary Gay Scanlon (Democratic)Denny Heck (Democratic)Mike Quigley (Democratic)James P. McGovern (Democratic)William R. Keating (Democratic)Rick Larsen (Democratic)Peter Welch (Democratic)Albio Sires (Democratic)Lori Trahan (Democratic)Suzanne Bonamici (Democratic)Ed Perlmutter (Democratic)Zoe Lofgren (Democratic)Cheri Bustos (Democratic)Bradley Scott Schneider (Democratic)Lloyd Doggett (Democratic)Debbie Wasserman Schultz (Democratic)Susan Wild (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Medicare Buy-In and Health Care Stabilization Act of 2019 This bill establishes a Medicare buy-in option for certain qualifying individuals and makes a series of other changes relating to health care costs. Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option. The bill also (1) establishes a supplemental option under Medicare to cover cost-sharing for beneficiaries; (2) repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs; and (3) establishes an individual market reinsurance program relating to coverage of high-cost individuals, as specified.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 25, 2019
Introduced in House
Feb 25, 2019
Referred to the Subcommittee on Health.
Feb 25, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 26, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Subcommittee Hearings Held.
  • February 25, 2019
    Introduced in House


  • February 25, 2019
    Referred to the Subcommittee on Health.


  • February 25, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 26, 2019
    Referred to the Subcommittee on Health.


  • December 10, 2019
    Subcommittee Hearings Held.

Health

Related Bills

  • HR 116-275: Medicare Prescription Drug Price Negotiation Act of 2019
  • S 116-964: Marketplace Certainty Act
  • HR 116-4652: Individual Health Insurance Marketplace Improvement Act
Advisory bodiesCongressional oversightDepartment of Health and Human ServicesExecutive agency funding and structureGovernment information and archivesGovernment studies and investigationsGovernment trust fundsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careIncome tax creditsInflation and pricesInsurance industry and regulationMedicarePrescription drugsPublic contracts and procurementState and local government operations

Medicare Buy-In and Health Care Stabilization Act of 2019

USA116th CongressHR-1346| House 
| Updated: 12/10/2019
Medicare Buy-In and Health Care Stabilization Act of 2019 This bill establishes a Medicare buy-in option for certain qualifying individuals and makes a series of other changes relating to health care costs. Specifically, the bill allows individuals aged 50 to 64 to enroll in Medicare if such individuals would otherwise qualify for Medicare at the age of 65. The Centers for Medicare & Medicaid Services (CMS) must determine enrollment periods and set premiums for the buy-in option established under the bill, in accordance with specified requirements. The CMS must also award grants to states and nonprofit organizations for outreach and enrollment activities relating to the buy-in option. The bill also (1) establishes a supplemental option under Medicare to cover cost-sharing for beneficiaries; (2) repeals provisions that prohibit the CMS from negotiating the prices of prescription drugs; and (3) establishes an individual market reinsurance program relating to coverage of high-cost individuals, as specified.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 25, 2019
Introduced in House
Feb 25, 2019
Referred to the Subcommittee on Health.
Feb 25, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 26, 2019
Referred to the Subcommittee on Health.
Dec 10, 2019
Subcommittee Hearings Held.
  • February 25, 2019
    Introduced in House


  • February 25, 2019
    Referred to the Subcommittee on Health.


  • February 25, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 26, 2019
    Referred to the Subcommittee on Health.


  • December 10, 2019
    Subcommittee Hearings Held.
Brian Higgins

Brian Higgins

Democratic Representative

New York

Cosponsors (51)
Tim Ryan (Democratic)Jared F. Golden (Democratic)Gilbert Ray Cisneros (Democratic)Adam B. Schiff (Democratic)James R. Langevin (Democratic)Ed Case (Democratic)Kathleen M. Rice (Democratic)Darren Soto (Democratic)John A. Yarmuth (Democratic)Max Rose (Democratic)Joe Courtney (Democratic)Pete Aguilar (Democratic)Dina Titus (Democratic)Michael F. Doyle (Democratic)Suzan K. DelBene (Democratic)Paul Tonko (Democratic)Wm. Lacy Clay (Democratic)Collin C. Peterson (Democratic)Anthony G. Brown (Democratic)Ann Kirkpatrick (Democratic)Daniel T. Kildee (Democratic)Ro Khanna (Democratic)Alan S. Lowenthal (Democratic)Ann M. Kuster (Democratic)Sean Patrick Maloney (Democratic)Brendan F. Boyle (Democratic)Matt Cartwright (Democratic)John B. Larson (Democratic)Gregory W. Meeks (Democratic)David E. Price (Democratic)Hakeem S. Jeffries (Democratic)Raja Krishnamoorthi (Democratic)Theodore E. Deutch (Democratic)Eleanor Holmes Norton (Democratic)Mary Gay Scanlon (Democratic)Denny Heck (Democratic)Mike Quigley (Democratic)James P. McGovern (Democratic)William R. Keating (Democratic)Rick Larsen (Democratic)Peter Welch (Democratic)Albio Sires (Democratic)Lori Trahan (Democratic)Suzanne Bonamici (Democratic)Ed Perlmutter (Democratic)Zoe Lofgren (Democratic)Cheri Bustos (Democratic)Bradley Scott Schneider (Democratic)Lloyd Doggett (Democratic)Debbie Wasserman Schultz (Democratic)Susan Wild (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 116-275: Medicare Prescription Drug Price Negotiation Act of 2019
  • S 116-964: Marketplace Certainty Act
  • HR 116-4652: Individual Health Insurance Marketplace Improvement Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advisory bodiesCongressional oversightDepartment of Health and Human ServicesExecutive agency funding and structureGovernment information and archivesGovernment studies and investigationsGovernment trust fundsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careIncome tax creditsInflation and pricesInsurance industry and regulationMedicarePrescription drugsPublic contracts and procurementState and local government operations